Dormant Company Accounts - IVY MEDICAL CHEMICALS DEVELOPMENT LIMITED

Dormant Company Accounts - IVY MEDICAL CHEMICALS DEVELOPMENT LIMITED


true 2019-07-01 2020-06-30 false 03426975 uk-bus:Director1 2019-07-01 2020-06-30 03426975 uk-bus:Director2 2019-07-01 2020-06-30 03426975 2019-07-01 2020-06-30 03426975 2020-06-30 03426975 uk-bus:EntityHasNeverTraded 2019-07-01 2020-06-30 03426975 uk-bus:FRS102 2019-07-01 2020-06-30 03426975 uk-bus:FullAccounts 2019-07-01 2020-06-30 03426975 uk-bus:AuditExempt-NoAccountantsReport 2019-07-01 2020-06-30 03426975 2019-06-30 03426975 uk-bus:OrdinaryShareClass1 2019-07-01 2020-06-30 03426975 uk-bus:OrdinaryShareClass2 2019-07-01 2020-06-30 03426975 uk-bus:OrdinaryShareClass3 2019-07-01 2020-06-30 03426975 uk-bus:PreferenceShareClass1 2019-07-01 2020-06-30 03426975 uk-bus:PreferenceShareClass2 2019-07-01 2020-06-30 03426975 uk-bus:PreferenceShareClass3 2019-07-01 2020-06-30 03426975 uk-core:ShareCapitalPreferenceShares 2020-06-30 03426975 uk-core:ShareCapitalPreferenceShares 2019-06-30 iso4217:GBP xbrli:shares

Registered Number 03426975

IVY MEDICAL CHEMICALS DEVELOPMENT LIMITED

Dormant Accounts

30 June 2020

IVY MEDICAL CHEMICALS DEVELOPMENT LIMITED Registered Number 03426975

Balance Sheet as at 30 June 2020

2020 2019
£ £
Called up share capital not paid
100
100
Net assets
100
100
Issued share capital
1000000 ordinary Shares of £ 0.0001 each 100 100
Total Shareholder funds
100
100

STATEMENTS

  1. For the year ending 30 June 2020 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 10 November 2020

And signed on their behalf by:
Roger Wood, Director